Header

UZH-Logo

Maintenance Infos

Resource allocation to brain research in Switzerland


Jäger, M; Lekander, I; Sobocki, P; Schwab, M E; Rössler, W (2008). Resource allocation to brain research in Switzerland. Swiss Medical Weekly, 138(23-24):335-339.

Abstract

QUESTIONS UNDER STUDY: This study represents a first attempt at estimating Swiss resource allocation to brain research including both public and private spending. METHODS: In order to estimate public spending (by governments and charities) a survey was conducted to evaluate the way brain research is funded across Europe and especially in Switzerland. Industry funding was measured using different approaches including a survey of pharmaceutical expenditures and the costs of developing new drugs. RESULTS: Private spending is at a reasonable level because a highly developed Swiss pharmaceutical industry invests significantly in this branch of science. However, public spending is at a low level compared to other European countries, although Switzerland is the only European country where the total funding per capita exceeds that of US funding. CONCLUSIONS: A detailed investigation of Swiss resource allocation to different branches of biomedical research is warranted. Brain research should be an important part of such a study. The United States and the European Union have selected brain research as one of their priority areas within health related research. The present figures indicate that this may also be justified in Switzerland.

Abstract

QUESTIONS UNDER STUDY: This study represents a first attempt at estimating Swiss resource allocation to brain research including both public and private spending. METHODS: In order to estimate public spending (by governments and charities) a survey was conducted to evaluate the way brain research is funded across Europe and especially in Switzerland. Industry funding was measured using different approaches including a survey of pharmaceutical expenditures and the costs of developing new drugs. RESULTS: Private spending is at a reasonable level because a highly developed Swiss pharmaceutical industry invests significantly in this branch of science. However, public spending is at a low level compared to other European countries, although Switzerland is the only European country where the total funding per capita exceeds that of US funding. CONCLUSIONS: A detailed investigation of Swiss resource allocation to different branches of biomedical research is warranted. Brain research should be an important part of such a study. The United States and the European Union have selected brain research as one of their priority areas within health related research. The present figures indicate that this may also be justified in Switzerland.

Statistics

Citations

Dimensions.ai Metrics
1 citation in Web of Science®
1 citation in Scopus®
1 citation in Microsoft Academic
Google Scholar™

Altmetrics

Downloads

66 downloads since deposited on 22 Jan 2009
14 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > Brain Research Institute
04 Faculty of Medicine > Psychiatric University Hospital Zurich > Clinic for Clinical and Social Psychiatry Zurich West (former)
Dewey Decimal Classification:570 Life sciences; biology
610 Medicine & health
Language:English
Date:2008
Deposited On:22 Jan 2009 12:23
Last Modified:18 Feb 2018 10:30
Publisher:EMH Swiss Medical Publishers
ISSN:0036-7672
Additional Information:Free full text article
OA Status:Gold
Official URL:http://www.smw.ch/docs/pdf200x/2008/23/smw-12081.pdf
Related URLs:http://www.smw.ch/docs/archive200x/2008/23/smw-12081.html (Publisher)
http://www.smw.ch/dfe/set_archiv.asp (Publisher)
PubMed ID:18561038

Download

Download PDF  'Resource allocation to brain research in Switzerland'.
Preview
Filetype: PDF
Size: 1MB